SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Target Corp – ‘10-K’ for 1/28/17 – ‘ZIP’

On:  Wednesday, 3/8/17, at 4:22pm ET   ·   For:  1/28/17   ·   Accession #:  27419-17-8   ·   File #:  1-06049

Previous ‘10-K’:  ‘10-K’ on 3/11/16 for 1/30/16   ·   Next:  ‘10-K’ on 3/14/18 for 2/3/18   ·   Latest:  ‘10-K’ on 3/13/24 for 2/3/24   ·   8 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 3/08/17  Target Corp                       10-K        1/28/17  147:13M

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML    927K 
 2: EX-10.CC    Material Contract                                   HTML     48K 
 3: EX-10.I     Material Contract                                   HTML    285K 
 4: EX-10.S     Material Contract                                   HTML     68K 
 5: EX-10.U     Material Contract                                   HTML     69K 
 7: EX-21       Subsidiaries List                                   HTML     36K 
 8: EX-23       Consent of Experts or Counsel                       HTML     39K 
 9: EX-24       Power of Attorney                                   HTML     91K 
 6: EX-12       Statement re: Computation of Ratios                 HTML     48K 
10: EX-31.A     Certification -- §302 - SOA'02                      HTML     43K 
11: EX-31.B     Certification -- §302 - SOA'02                      HTML     43K 
12: EX-32.A     Certification -- §906 - SOA'02                      HTML     38K 
13: EX-32.B     Certification -- §906 - SOA'02                      HTML     38K 
20: R1          Document and Entity Information                     HTML     65K 
21: R2          Consolidated Statements of Operations               HTML    113K 
22: R3          Consolidated Statements of Comprehensive Income     HTML     54K 
23: R4          Consolidated Statements of Comprehensive Income     HTML     43K 
                (Parenthetical)                                                  
24: R5          Consolidated Statements of Financial Position       HTML    134K 
25: R6          Consolidated Statements of Financial Position       HTML     58K 
                (Parenthetical)                                                  
26: R7          Consolidated Statements of Cash Flows               HTML    148K 
27: R8          Consolidated Statements of Cash Flows               HTML     40K 
                (Parenthetical)                                                  
28: R9          Consolidated Statements of Shareholders'            HTML     87K 
                Investment                                                       
29: R10         Summary of Accounting Policies                      HTML     46K 
30: R11         Revenues                                            HTML     43K 
31: R12         Cost of Sales and Selling, General and              HTML     44K 
                Administrative Expenses                                          
32: R13         Consideration Received from Vendors                 HTML     40K 
33: R14         Advertising Costs                                   HTML     47K 
34: R15         Pharmacies Transaction                              HTML    102K 
35: R16         Canada Exit                                         HTML    102K 
36: R17         Restructuring Initiatives                           HTML     40K 
37: R18         Credit Card Profit Sharing                          HTML     39K 
38: R19         Fair Value Measurements                             HTML     79K 
39: R20         Cash Equivalents                                    HTML     42K 
40: R21         Inventory                                           HTML     42K 
41: R22         Other Current Assets                                HTML     47K 
42: R23         Property and Equipment                              HTML     55K 
43: R24         Other Noncurrent Assets                             HTML     48K 
44: R25         Goodwill and Intangible Assets                      HTML     74K 
45: R26         Accounts Payable                                    HTML     39K 
46: R27         Accrued and Other Current Liabilities               HTML     54K 
47: R28         Commitments and Contingencies                       HTML     49K 
48: R29         Notes Payable and Long-Term Debt                    HTML     77K 
49: R30         Derivative Financial Instruments                    HTML     80K 
50: R31         Leases                                              HTML     83K 
51: R32         Income Taxes                                        HTML    111K 
52: R33         Other Noncurrent Liabilities                        HTML     51K 
53: R34         Share Repurchase                                    HTML     46K 
54: R35         Share-Based Compensation                            HTML    110K 
55: R36         Defined Contribution Plans                          HTML     56K 
56: R37         Pension and Postretirement Health Care Plans        HTML    194K 
57: R38         Accumulated Other Comprehensive Income              HTML     61K 
58: R39         Segment Reporting                                   HTML     88K 
59: R40         Quarterly Results (Unaudited)                       HTML    243K 
60: R41         Summary of Accounting Policies (Policies)           HTML    149K 
61: R42         Advertising Costs (Tables)                          HTML     47K 
62: R43         Pharmacies Transaction (Tables)                     HTML     71K 
63: R44         Canada Exit (Tables)                                HTML     98K 
64: R45         Fair Value Measurements (Tables)                    HTML     78K 
65: R46         Other Current Assets (Tables)                       HTML     47K 
66: R47         Property and Equipment (Tables)                     HTML     54K 
67: R48         Other Noncurrent Assets (Tables)                    HTML     48K 
68: R49         Goodwill and Intangible Assets (Tables)             HTML     69K 
69: R50         Accrued and Other Current Liabilities (Tables)      HTML     54K 
70: R51         Notes Payable and Long-Term Debt (Tables)           HTML     79K 
71: R52         Derivative Financial Instruments (Tables)           HTML     76K 
72: R53         Leases (Tables)                                     HTML     76K 
73: R54         Income Taxes (Tables)                               HTML    109K 
74: R55         Other Noncurrent Liabilities (Tables)               HTML     50K 
75: R56         Share Repurchase (Tables)                           HTML     47K 
76: R57         Share-Based Compensation (Tables)                   HTML    109K 
77: R58         Defined Contribution Plans (Tables)                 HTML     52K 
78: R59         Pension and Postretirement Health Care Plans        HTML    199K 
                (Tables)                                                         
79: R60         Accumulated Other Comprehensive Income (Tables)     HTML     58K 
80: R61         Segment Reporting (Tables)                          HTML     84K 
81: R62         Quarterly Results (Unaudited) (Tables)              HTML    244K 
82: R63         Summary of Accounting Policies (Details)            HTML     42K 
83: R64         Revenues (Details)                                  HTML     48K 
84: R65         Advertising Costs (Details)                         HTML     43K 
85: R66         Pharmacies Transaction - Narrative (Details)        HTML     51K 
86: R67         Pharmacies Transaction - Schedule of Gain on        HTML     66K 
                Pharmacies and Clinics Transaction (Details)                     
87: R68         Canada Exit - Narrative (Details)                   HTML     55K 
88: R69         Canada Exit - Schedule of Income/(Loss) on          HTML     75K 
                Discontinued Operations (Details)                                
89: R70         Canada Exit - Schedule of Pretax Exit Costs         HTML     48K 
                (Details)                                                        
90: R71         Canada Exit - Schedule of Assets and Liabilities    HTML     54K 
                of Discontinued Operations (Details)                             
91: R72         Restructuring Initiatives - Narrative (Details)     HTML     43K 
92: R73         Credit Card Profit Sharing (Details)                HTML     39K 
93: R74         Fair Value Measurements - Schedule of Fair Value    HTML     66K 
                Measurements - Recurring Basis (Details)                         
94: R75         Fair Value Measurements - Schedule of Significant   HTML     43K 
                Financial Instruments not Measured at Fair Value                 
                (Details)                                                        
95: R76         Cash Equivalents (Details)                          HTML     44K 
96: R77         Inventory (Details)                                 HTML     39K 
97: R78         Other Current Assets (Details)                      HTML     47K 
98: R79         Property and Equipment (Details)                    HTML     62K 
99: R80         Other Noncurrent Assets (Details)                   HTML     47K 
100: R81         Goodwill and Intangible Assets - Narrative          HTML     50K  
                (Details)                                                        
101: R82         Goodwill and Intangible Assets - Schedule of        HTML     65K  
                Intangible Assets (Details)                                      
102: R83         Goodwill and Intangible Assets - Schedule of        HTML     48K  
                Estimated Amortization Expense (Details)                         
103: R84         Accounts Payable (Details)                          HTML     40K  
104: R85         Accrued and Other Current Liabilities (Details)     HTML     63K  
105: R86         Commitments and Contingencies - Narrative           HTML     65K  
                (Details)                                                        
106: R87         Notes Payable and Long-Term Debt - Narrative        HTML     73K  
                (Details)                                                        
107: R88         Notes Payable and Long-Term Debt - Schedule of      HTML     66K  
                Carrying Value and Maturities of Debt Portfolio                  
                (Details)                                                        
108: R89         Notes Payable and Long-Term Debt - Schedule of      HTML     50K  
                Required Principal Payments (Details)                            
109: R90         Notes Payable and Long-Term Debt - Schedule of      HTML     47K  
                Commercial Paper (Details)                                       
110: R91         Derivative Financial Instruments - Narrative        HTML     43K  
                (Details)                                                        
111: R92         Derivative Financial Instruments - Schedule of      HTML     53K  
                Outstanding Interest Rate Swap Summary (Details)                 
112: R93         Derivative Financial Instruments - Schedule of      HTML     55K  
                Classification and Fair Value (Details)                          
113: R94         Derivative Financial Instruments - Schedule of      HTML     41K  
                Derivative Contracts - Effect on Results of                      
                Operations (Details)                                             
114: R95         Leases - Narrative (Details)                        HTML     53K  
115: R96         Leases - Schedule of Rent Expense (Details)         HTML     43K  
116: R97         Leases - Schedule of Future Minimum Lease Payments  HTML    117K  
                (Details)                                                        
117: R98         Income Taxes - Narrative (Details)                  HTML     66K  
118: R99         Income Taxes - Schedule of Tax Rate Reconciliation  HTML     58K  
                - Continuing Operations (Details)                                
119: R100        Income Taxes - Schedule of Provision for Income     HTML     72K  
                Taxes (Details)                                                  
120: R101        Income Taxes - Schedule of Net Deferred Tax         HTML     71K  
                Asset/(Liability) (Details)                                      
121: R102        Income Taxes - Schedule of Reconciliation of        HTML     50K  
                Liability for Unrecognized Tax Benefits (Details)                
122: R103        Other Noncurrent Liabilities (Details)              HTML     57K  
123: R104        Share Repurchase - Schedule of Share Repurchases    HTML     44K  
                (Details)                                                        
124: R105        Share-Based Compensation - Narrative (Details)      HTML     93K  
125: R106        Share-Based Compensation - Schedule of Restricted   HTML     73K  
                Stock Activity and Performance Share Unit Activity               
                (Details)                                                        
126: R107        Share-Based Compensation - Schedule of Stock        HTML     71K  
                Option Activity (Details)                                        
127: R108        Share-Based Compensation - Schedule of Stock        HTML     44K  
                Option Exercises (Details)                                       
128: R109        Defined Contribution Plans (Details)                HTML     63K  
129: R110        Pension and Postretirement Health Care Plans -      HTML     52K  
                Schedule of Recognition of Funded/(Underfunded)                  
                Status (Details)                                                 
130: R111        Pension and Postretirement Health Care Plans -      HTML     52K  
                Schedule of Estimated Future Benefit Payments                    
                (Details)                                                        
131: R112        Pension and Postretirement Health Care Plans -      HTML     58K  
                Schedule of Net Pension Benefit Expense (Details)                
132: R113        Pension and Postretirement Health Care Plans -      HTML     43K  
                Schedule of Benefit Obligation Weighted Average                  
                Assumptions (Details)                                            
133: R114        Pension and Postretirement Health Care Plans -      HTML     46K  
                Schedule of Net Periodic Benefit Expense Weighted                
                Average Assumptions (Details)                                    
134: R115        Pension and Postretirement Health Care Plans -      HTML     78K  
                Narrative (Details)                                              
135: R116        Pension and Postretirement Health Care Plans -      HTML     64K  
                Schedule of Change in Projected Benefit Obligation               
                (Details)                                                        
136: R117        Pension and Postretirement Health Care Plans -      HTML     61K  
                Schedule of Change in Plan Assets (Details)                      
137: R118        Pension and Postretirement Health Care Plans -      HTML     61K  
                Schedule of Asset Category (Details)                             
138: R119        Pension and Postretirement Health Care Plans -      HTML     64K  
                Schedule of Fair Value Measurements (Details)                    
139: R120        Pension and Postretirement Health Care Plans -      HTML     57K  
                Schedule of Amounts in Accumulated Other                         
                Comprehensive Income (Details)                                   
140: R121        Accumulated Other Comprehensive Income (Details)    HTML     74K  
141: R122        Segment Reporting - Schedule of Business Segment    HTML     79K  
                Results (Details)                                                
142: R123        Segment Reporting - Schedule of Total Assets by     HTML     46K  
                Segments (Details)                                               
143: R124        Quarterly Results (Unaudited) - Schedule of         HTML    115K  
                Quarterly Results (Details)                                      
144: R125        Quarterly Results (Unaudited) - Summary of Sales    HTML     59K  
                by Product Category (Details)                                    
146: XML         IDEA XML File -- Filing Summary                      XML    265K  
145: EXCEL       IDEA Workbook of Financial Reports                  XLSX    136K  
14: EX-101.INS  XBRL Instance -- tgt-20170128                        XML   3.69M 
16: EX-101.CAL  XBRL Calculations -- tgt-20170128_cal                XML    404K 
17: EX-101.DEF  XBRL Definitions -- tgt-20170128_def                 XML    842K 
18: EX-101.LAB  XBRL Labels -- tgt-20170128_lab                      XML   2.55M 
19: EX-101.PRE  XBRL Presentations -- tgt-20170128_pre               XML   1.50M 
15: EX-101.SCH  XBRL Schema -- tgt-20170128                          XSD    296K 
147: ZIP         XBRL Zipped Folder -- 0000027419-17-000008-xbrl      Zip    345K  


‘ZIP’   —   XBRL Zipped Folder — 0000027419-17-000008-xbrl


This is an XBRL Zipped Folder.

        Download this zipped .zip folder
 
Files:tgt-20170128.xml
tgt-20170128.xsd
tgt-20170128_cal.xml
tgt-20170128_def.xml
tgt-20170128_lab.xml
tgt-20170128_pre.xml


8 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/13/24  Target Corp.                      10-K        2/03/24  131:11M
 3/08/23  Target Corp.                      10-K        1/28/23  127:12M
 3/09/22  Target Corp.                      10-K        1/29/22  124:11M
 3/10/21  Target Corp.                      10-K        1/30/21  130:12M
 7/13/17  SEC                               UPLOAD9/21/17    1:35K  Target Corp.
 6/12/17  SEC                               UPLOAD9/21/17    1:41K  Target Corp.
 5/30/17  SEC                               UPLOAD9/21/17    1:136K Target Corp.
 5/12/17  SEC                               UPLOAD9/21/17    1:137K Target Corp.
Top
Filing Submission 0000027419-17-000008   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 17, 9:21:43.2am ET